PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12385892-0	2002	Daunorubicin- and Ara-C-induced interphasic apoptosis of human type II leukemia cells is caspase-8-independent.	Daunorubicin	0-12	caspase 8	Homo sapiens	89-98	
12780785-6	2003	The ability of TRAIL and daunorubicin to induce super-additive apoptosis correlated with the ability of these agents to activate caspase 8 and to augment cellular levels of the truncated pro-apoptotic form of the BCL-2 family member BID.	Daunorubicin	25-37	caspase 8	Homo sapiens	129-138	
21333751-0	2011	Fe3O4 nanoparticles with daunorubicin induce apoptosis through caspase 8-PARP pathway and inhibit K562 leukemia cell-induced tumor growth in vivo.	Daunorubicin	25-37	caspase 8	Homo sapiens	63-72	
10216102-3	1999	Because apoptosis induced by anticancer drugs has been proposed to involve CD95/CD95 ligand interaction, we investigated the mechanism of caspase activation by daunorubicin, doxorubicin, etoposide, and mitomycin C.	Daunorubicin	160-172	caspase 8	Homo sapiens	138-145	
25226230-8	2014	Imaging and scWestern analysis of single glioblastoma cells dosed with the chemotherapeutic daunomycin showed both apoptotic (cleaved caspase 8- and annexin V-positive) and living cells.	Daunorubicin	92-102	caspase 8	Homo sapiens	134-143	
21062083-5	2011	Mitosomal daunorubicin plus amlodipine were about 97 nm, selectively accumulated in mitochondria, induced the swelling and disruption of mitochondria, dissipated the mitochondrial membrane potential, released a large amount of cytochrome C by translocation, cleaved Bid, and initiated a cascade of caspase 8 and 3 reactions.	Daunorubicin	10-22	caspase 8	Homo sapiens	298-307